Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parikh

Showing results (1031-1040 of 1,087) with videos related to

Pageof 109
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
End-stage renal disease among HIV-infected adults in North AmericaAlison G Abraham, Keri N Althoff, Yuezhou Jing, et al.
European Urology|January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory RevisitedMatthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 15, 2022
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID StudiesSteven G Coca, George Vasquez-Rios, Sherry G Mansour, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Lancet (London, England)|April 25, 2017
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policyAdeera Levin, Marcello Tonelli, Joseph Bonventre, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
JCO Oncology Practice|July 13, 2022
Supportive Oncology Care at Home Intervention for Patients With Pancreatic CancerRyan D Nipp, Eva Gaufberg, Charu Vyas, et al.
BMC Nephrology|June 2, 2025
Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKIAudrey A Shi, Anna Simone Andrawis, Aditya Biswas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Pageof 109

Showing results (1031-1040 of 1,087) with videos related to

Sort By:
Pageof 109
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 20, 2014
End-stage renal disease among HIV-infected adults in North AmericaAlison G Abraham, Keri N Althoff, Yuezhou Jing, et al.
European Urology|January 9, 2021
The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory RevisitedMatthew P Deek, Kim Van der Eecken, Ryan Phillips, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 15, 2022
Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID StudiesSteven G Coca, George Vasquez-Rios, Sherry G Mansour, et al.
JCO Precision Oncology|July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal CancerSusan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Cancer Discovery|February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal CancerMehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
Lancet (London, England)|April 25, 2017
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policyAdeera Levin, Marcello Tonelli, Joseph Bonventre, et al.
Theranostics|September 30, 2024
Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studiesShadi A Esfahani, Hua Ma, Shriya Krishna, et al.
JCO Oncology Practice|July 13, 2022
Supportive Oncology Care at Home Intervention for Patients With Pancreatic CancerRyan D Nipp, Eva Gaufberg, Charu Vyas, et al.
BMC Nephrology|June 2, 2025
Using vascular biomarkers to assess heart failure event risk in hospitalized patients with and without AKIAudrey A Shi, Anna Simone Andrawis, Aditya Biswas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2025
Genomic landscape of clinically acquired resistance alterations in patients treated with KRAS<sup>G12C</sup> inhibitorsJ M Riedl, F Fece de la Cruz, J J Lin, et al.
Pageof 109